Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
出版年份 2017 全文链接
标题
Optimization strategies aimed to increase the efficacy of H. pylori
eradication therapies
作者
关键词
-
出版物
HELICOBACTER
Volume 22, Issue 4, Pages e12392
出版商
Wiley
发表日期
2017-05-03
DOI
10.1111/hel.12392
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments ofHelicobacter pyloriinfection
- (2016) P.-Y. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment
- (2016) Ignasi Puig et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hybrid, sequential and concomitant therapies forHelicobacter pylorieradication: A systematic review and meta-analysis
- (2016) Zhi-Qiang Song et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication ofHelicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
- (2016) Stefan Sorin Arama et al. Gastroenterology Research and Practice
- Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
- (2015) J. Molina-Infante et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistance
- (2015) I. Thung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
- (2015) Jyh-Chin Yang et al. Clinical Gastroenterology and Hepatology
- Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-lineHelicobacter pyloritherapy
- (2015) Wei Zhang et al. GUT
- Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
- (2015) Seong tae Lee et al. Gut and Liver
- Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype
- (2015) David Y. Graham HELICOBACTER
- Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for Helicobacter pylori Eradication
- (2015) Lei He et al. INTERNAL MEDICINE
- Hybridvssequential therapy for eradication ofHelicobacter pyloriin Taiwan: A prospective randomized trial
- (2015) Kuan-Yang Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Hybrid therapy forHelicobacter pyloriinfection: A systemic review and meta-analysis
- (2015) Ping-I Hsu WORLD JOURNAL OF GASTROENTEROLOGY
- Comparative effectiveness and tolerance of treatments forHelicobacter pylori: systematic review and network meta-analysis
- (2015) Bao-Zhu Li et al. BMJ-British Medical Journal
- Comparative effectiveness and tolerance of treatments forHelicobacter pylori: systematic review and network meta-analysis
- (2015) Bao-Zhu Li et al. BMJ-British Medical Journal
- Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in Thailand
- (2015) Chanagune Srinarong et al. Asian Pacific Journal of Cancer Prevention
- 245 Effects of Different Dosing Schedules of Amoxicillin on the Eradication Rates of Helicobacter pylori by Triple Therapy With a Proton Pump Inhibitor, Amoxicillin, and Either Clarithromycin or Metronidazole
- (2015) Takahisa Furuta et al. GASTROENTEROLOGY
- Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori
- (2014) J. C. Delchier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review: Efficacy and Safety of Hybrid Therapy forHelicobacter pyloriInfection: A Systematic Review and Meta-analysis
- (2014) Ben Wang et al. HELICOBACTER
- Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an ExcellentHelicobacter pyloriEradication Rate
- (2014) Jeng-Yih Wu et al. HELICOBACTER
- Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
- (2014) V. De Francesco et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
- (2014) Javier Molina-Infante WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment ofHelicobacter pyloriinfection: Current status and future concepts
- (2014) Jyh-Chin Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment
- (2013) Nadim S. Jafri ANNALS OF INTERNAL MEDICINE
- Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
- (2013) Xiao Liang et al. Clinical Gastroenterology and Hepatology
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
- (2013) Vikram Kate et al. DRUGS
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study
- (2013) Bilal Ergül et al. HELICOBACTER
- The Effects of Multistrain Probiotic Compound on Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo-Controlled Triple-Blind Study
- (2013) Ahmad Shavakhi et al. HELICOBACTER
- Clinical Outcomes of Two-Week Sequential and Concomitant Therapies forHelicobacter pyloriEradication: A Randomized Pilot Study
- (2013) Ji Hyun Lim et al. HELICOBACTER
- Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
- (2013) Jingxian Liao et al. HELICOBACTER
- Effect of dosing schemes of amoxicillin on eradication rates ofHelicobacter pyloriwith amoxicillin-based triple therapy
- (2013) Takahisa Furuta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
- (2013) Hui-Lin Tang et al. PLoS One
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: sequential therapy for Helicobacter pylori eradication in children
- (2012) A. Horvath et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Standard triple and sequential therapies for Helicobacter pylori eradication: An update
- (2012) Angelo Zullo et al. European Journal of Internal Medicine
- Which Therapy for Helicobacter pylori Infection?
- (2012) David Y. Graham et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
- (2012) Marco Manfredi et al. HELICOBACTER
- Helicobacter pyloriEradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial
- (2012) Jie Liang et al. HELICOBACTER
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Greater Than 95% Success with 14-day Bismuth Quadruple Anti-Helicobacter pyloriTherapy: A Pilot Study in US Hispanics
- (2012) Cesar O. Salazar et al. HELICOBACTER
- Pilot Studies to Identify the Optimum Duration of Concomitant Helicobacter pylori Eradication Therapy in Thailand
- (2012) Chutima Kongchayanun et al. HELICOBACTER
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
- (2012) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comparative Study of Helicobacter pylori Eradication Rates With 5-day Quadruple “Concomitant” Therapy and 7-day Standard Triple Therapy
- (2012) Seung Young Kim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comparison of sequential and 7-, 10-, 14-d triple therapy forHelicobacter pyloriinfection
- (2012) Hyuk Soon Choi WORLD JOURNAL OF GASTROENTEROLOGY
- Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
- (2011) Jun-Won Chung et al. HELICOBACTER
- Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population
- (2011) Kazutoshi Hori et al. HELICOBACTER
- A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
- (2011) Ahmet Burak Toros et al. HELICOBACTER
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
- (2011) E Robert Greenberg et al. LANCET
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Optimal therapy for Helicobacter pylori infections
- (2011) Emiko Rimbara et al. Nature Reviews Gastroenterology & Hepatology
- Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results
- (2010) David Y. Graham Clinical Gastroenterology and Hepatology
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
- (2010) Takahisa Furuta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
- (2010) Byoung Hwan Lee et al. HELICOBACTER
- High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
- (2010) Qinjuan Sun et al. HELICOBACTER
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Helicobacter pyloriInfection
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- (2010) Yuqin Li et al. WIENER KLINISCHE WOCHENSCHRIFT
- Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children
- (2009) Luigi Gatta et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Helicobacter pyloriEradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
- (2009) Tajana Filipec Kanizaj et al. HELICOBACTER
- Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication
- (2009) Abdallah Said Essa et al. HELICOBACTER
- Editorial: H. pylori Treatment: New Wine in Old Bottles?
- (2008) Nimish Vakil AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies
- (2008) David Y. Graham Clinical Gastroenterology and Hepatology
- Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
- (2008) S. Di Caro et al. DIGESTIVE AND LIVER DISEASE
- ¿Son más eficaces dosis más elevadas de inhibidores de la bomba de protones para el tratamiento de la infección por Helicobacter pylori?
- (2008) Albert Villoria Gastroenterologia y Hepatologia
- Comparative Study ofHelicobacter pyloriEradication Rates of Twice-Versus Four-Times-Daily Amoxicillin Administered with Proton Pump lnhibitor and Clarithromycin: A Randomized Study
- (2008) Seung Young Kim et al. HELICOBACTER
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis
- (2008) Fujun Zhao et al. HELICOBACTER
- Sequential therapy vs. standard triple therapies forHelicobacter pyloriinfection: a meta-analysis
- (2008) J. L. Tong et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
- (2008) Yusuf Usta et al. JOURNAL OF GASTROENTEROLOGY
- Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
- (2008) Alexander C Ford et al. WORLD JOURNAL OF GASTROENTEROLOGY
- “Rescue” regimens after Helicobacter pylori treatment failure
- (2008) Javier P Gisbert WORLD JOURNAL OF GASTROENTEROLOGY
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
- (2007) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started